ITMCTR2000003300尚未招募4 期
Clinical study for the effect of Zhenyuan capsule on Cardiopulmonary function in patients with stable Coronary Heart Disease
Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75(—)
- 性别
- All
入选标准
- •1. Results of coronary angiography or spiral CT: coronary stenosis >= 50%, or clear history of myocardial infarction, or stable condition more than one month after ACS treatment (PCI, CABG);
- •2. Patients with LVEF >= 40%;
- •3. Patients with angina I-II (CCS grade);
- •4. Patients with Qi deficiency and blood stasis syndrome;
- •5. Patients aged 18 to 75 years;
- •6. The patients who are in line with the risk stratification of coronary heart disease and have low risk of cardiac rehabilitation can be rehabilitated by exercise cardio pulmonary;
- •7. Patients willing to sign informed consent.
排除标准
- •1. Patients with acute myocardial infarction, unstable angina, or within one month after PCI or CABG;
- •2. Patients with absolute and relative contraindications for cardiopulmonary exercise test;
- •3. Patients who took Zhenyuan capsule in the last month or who participated in other clinical trials in the last month;
- •4. In the patients with renal insufficiency, serum creatinine was more than 2.5mg/dl in men and more than 2.0mg/dl in women;
- •5. Patients with obvious liver disease or ALT and AST were 3 times higher than the upper limit of normal;
- •6. New York Heart Function (NYHA) grade IV, or patients with recurrent malignant arrhythmias;
- •7. Patients with chronic obstructive pulmonary disease or even respiratory failure, or patients with pulmonary infection;
- •8. Patients with diabetes mellitus whose blood glucose >=13.7mmol/l or HbA1c was >= 9.5%;
- •9. Pregnant or preparing pregnant women and lactating women;
- •10. Patients with acute cerebrovascular disease; malignant tumor or patients with life expectancy less than 1 year; patients with severe hematopoietic system disease; patients with severe mental disease;
- •11. Patients who are allergic to known components of the study drug.
研究者
相似试验
尚未招募
4 期
A clinical study of Quanduzhong capsule in treating primary osteoporosis (kidney-yang deficiency syndrome)ITMCTR2100005285Wangjing Hospital of China Academy of Chinese Medical Sciences
尚未招募
4 期
Efficacy and safety of Zhenyuan capsule in improving the glucose metabolism of pre-diabetes patients: a randomized controlled trialITMCTR2000003411Xiyuan Hospital, China Academy of Chinese Medical Sciences
尚未招募
4 期
Clinical study of Xuefu Zhuyu Capsule in the treatment of acute chest pain after thoracoscopic surgery for early non-small cell lung cancerSCLCITMCTR2200005757Peking University People's Hospital
尚未招募
1 期
Clinical study of Shenyuan Yiqi Huoxue Capsule on cardiopulmonary motor function and quality of life in patients with Ischemic CardiomyopathyIschemic cardiomyopathyITMCTR2200006813Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
招募中
1 期
Clinical study of Zhenzhu Qingyuan granule in the treatment of gastroesophageal reflux disease of liver-stomach heat retention typeGastrointestinal reflex diseaseITMCTR2000003674Xiyuan Hospital CACMS
